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A B S T R A C T
Introduction: We aimed to uncover the pattern of network-level changes in neuronal function in Spinocerebellar
ataxia type 3 (SCA3).
Methods: 17 genetically-conﬁrmed SCA3 patients and 16 controls underwent structural MRI and static resting-
state [18F]‑Fluoro‑deoxyglucose Positron Emission Tomography (FDG-PET) imaging. A SCA3-related pattern
(SCA3-RP) was identiﬁed using a multivariate method (scaled subproﬁle model and principal component ana-
lysis (SSM PCA)). Participants were evaluated with the Scale for Assessment and Rating of Ataxia (SARA) and
with neuropsychological examination including tests for language, executive dysfunction, memory, and in-
formation processing speed. The relationships between SCA3-RP expression and clinical scores were explored.
Voxel based morphology (VBM) was applied on MRI-T1 images to assess possible correlations between FDG
reduction and grey matter atrophy.
Results: The SCA3-RP disclosed relative hypometabolism of the cerebellum, caudate nucleus and posterior
parietal cortex, and relatively increased metabolism in somatosensory areas and the limbic system. This topo-
graphy, which was not explained by regional atrophy, correlated signiﬁcantly with ataxia (SARA) scores
(ρ=0.72; P=0.001). SCA3 patients showed signiﬁcant deﬁcits in executive function and information pro-
cessing speed, but only letter ﬂuency correlated with SCA3-RP expression (ρ=0.51; P=0.04, uncorrected for
multiple comparisons).
Conclusion: The SCA3 metabolic proﬁle reﬂects network-level alterations which are primarily associated with
the motor features of the disease. Striatum decreases additional to cerebellar hypometabolism underscores an
intrinsic extrapyramidal involvement in SCA3. Cerebellar-posterior parietal hypometabolism together with
anterior parietal (sensory) cortex hypermetabolism may reﬂect a shift from impaired feedforward to compen-
satory feedback processing in higher-order motor control. The demonstrated SCA3-RP provides basic insight in
cerebral network changes in this disease.
1. Introduction
Spinocerebellar ataxia type 3 (SCA3, previously coined Machado-
Joseph disease) is a neurodegenerative disease caused by trinucleotide
(CAG) repeat expansion in exon 10 of the ATXN3 gene on chromosome
14 (p32). The cerebellum is most severely aﬀected, with ataxia as key
feature, but patients may also develop pyramidal and extra-pyramidal
signs, neuropathy and oculomotor dysfunction (Riess et al., 2008), as
well as cognitive problems (Braga-Neto et al., 2014).
Pathology in variable brain structures (including the cerebellum,
brainstem, thalamus, basal ganglia, and cerebral cortex) (Seidel et al.,
2012; Rub et al., 2008; Rub et al., 2013) may explain the variety of
symptoms, although dysfunction may also arise from functional dis-
connection from the cerebellum. Imaging cerebral metabolism with
[18F]‑Fluoro‑deoxyglucose Positron Emission Tomography (FDG-PET)
enables assessment of distributed cerebral dysfunction (Reivich et al.,
1979). The obtained FDG-PET (as well as perfusion SPECT) data are
commonly analyzed with univariate models which have consistently
demonstrated cerebellar hypo-activity, but showed variable results re-
garding the involvement of extra-cerebellar structures such as the
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brainstem (Soong et al., 1997; Soong and Liu, 1998; Wullner et al.,
2005; Wang et al., 2007), thalamus (Wullner et al., 2005), lentiform
nucleus (Wang et al., 2007), limbic lobe (Wang et al., 2007; Braga-Neto
et al., 2012a), and occipital cortex (Soong et al., 1997; Soong and Liu,
1998; Braga-Neto et al., 2012a).
While univariate approaches treat every region (voxel) individually,
multivariate analysis enables assessment of network-level alterations.
With the scaled subproﬁle model with principal component analysis
(SSM PCA) (Spetsieris and Eidelberg, 2011) disease-speciﬁc patterns
have been identiﬁed in several neurodegenerative disorders (Meles
et al., 2017; Niethammer and Eidelberg, 2012).
Here, we studied FDG-PET data of SCA3 patients with SSM PCA to
gain insight into the pattern of changed neuronal activity in this dis-
ease. To understand the relation with symptoms, correlations between
expression of the SCA3 metabolic pattern and clinical parameters were
analyzed. Moreover, to assess whether the metabolic pattern reﬂects
network-level activity changes beyond regional atrophy due to neu-
ronal cell-loss, we additionally performed a voxel-based morphometry




We included 17 genetically-conﬁrmed SCA3 patients. Inclusion
criteria were age 18–65 years and absence of other neurological dis-
orders. In addition, we studied 16 age, gender and education-matched
healthy controls. Healthy controls did not have a history of neurological
disease, nor a family history of cerebellar disorders. Severity of ataxia
was assessed in both groups by an experienced neurologist (HPHK,
JJdV) with the Scale for Assessment and Rating of Ataxia (SARA)
(Schmitz-Hubsch et al., 2006).
Neuropsychological tests selected for this study were based on
previously published results in SCA3 patients (Braga-Neto et al., 2014).
These tests evaluated language (Semantic Fluency), memory (Dutch
version of the Rey Auditory Verbal Learning Test; RAVLT), and ex-
ecutive (Letter Fluency) domains. Information processing speed was
measured with the Symbol Digits Modalities test (SDMT). Aﬀective
symptoms were assessed with the Hospital Anxiety and Depression
Scale (HADS).
The study was approved by the Ethics Committee of the University
Medical Center Groningen (NL45036.042.13). Voluntary written in-
formed consent was obtained from each subject after verbal and written
explanation of the study, in accordance with the Declaration of
Helsinki.
2.2. Image acquisition
Static FDG-PET scanning was performed on a Siemens Biograph
mCT-64 PET/CT camera (Siemens, Munich, Germany) in a three-di-
mensional mode, 30min after intravenous injection of 200MBq of 18F-
FDG, with a frame-duration of 5min. A low-dose computed tomography
transmission scan was performed for attenuation correction. Images
were reconstructed with OSEM3D, including point-spread function and
time-of-ﬂight modeling (3 iterations/21 subsets, matrix 400) and
smoothed with a Gaussian 2mm full-width at half-maximum ﬁlter.
Central nervous system depressants were discontinued in all subjects for
at least 24 h before FDG-PET scanning. This included clonazepam,
which was used by three patients. One patient used levodopa at the
time of the study, which was not discontinued. FDG uptake and image
acquisition were performed in a resting state with the subject's eyes
closed in a dimly lit room with minimal auditory stimulation.
MRI-T1 images were acquired for registration purposes. Subjects
were scanned at a Philips Achieva 3.0T MRI scanner (Philips, Best, The
Netherlands) with a 32-channel head coil. A 3D T1 TFE image was
acquired for each subject using the following parameters: 160 sagittal
slices without gap, FOV (ap× rl× fh) 256× 160×256mm, acquired
matrix 256× 256, voxel size 1×1×1mm, repetition time 7.8 ms,
echo time 3.6ms and ﬂip angle 8 degrees for a total scan duration of
10min and 14 s.
2.3. Image registration
Prior to the SSM PCA analysis, the PET images of all subjects needed
to be in registration. First, from the T1 images the brains were extracted
from the rest of the head using FreeSurfer (Segonne et al., 2004;
FreeSurfer, 2012) (version 5.3, with default parameters, running on
Ubuntu 12.04.5 LTS), resulting in a brain mask per subject. Tools from
the FSL (Smith et al., 2004) toolbox (version 5.0.8, running under
Ubuntu 10.04 LTS) were used for subsequent registration. Using FLIRT
(Jenkinson and Smith, 2001; Jenkinson et al., 2002), the PET images
were registered to the brain mask produced by FreeSurfer (i.e. intra-
subject registration), and the transformation parameters were stored.
Here, default parameters were used except for the cost and search-cost
options (set to normalized mutual information) and the degrees of
freedom (6, i.e. allowing for rotations and translations). The MRI data
were registered to the MNI 2mm template provided with FSL by ﬁrst
using FLIRT to register the subject's brain mask linearly with the MNI
2mm brain image (using default parameters). The resulting transfor-
mation parameters were used as a starting estimate for the nonlinear
registration of the subject's T1 image with the MNI 2mm head volume
using FNIRT (Andersson et al., 2007) (using default parameters, as
stored in the T1_2_MNI152_2mm.cnf ﬁle supplied with FSL). The linear
transformation parameters resulting from registering the PET image to
the brain mask and the nonlinear transformation parameters resulting
from registering the T1 image to the MNI volume were combined (to
minimize the number of interpolation steps) and applied to the PET
images. Finally, these images were smoothed with an 8mm full-width
at half-maximum ﬁlter Gaussian kernel and stored for subsequent
analyses.
2.4. Identiﬁcation of the SCA3-RP
We applied an automated algorithm written in-house, based on the
SSM PCA method of Spetsieris et al. (2015), implemented in Matlab
(version 2012b; MathWorks, Natick, MA). First, a 35% threshold of the
whole-brain intensity maximum was applied to each individual FDG-
PET image to remove out-of-brain voxels; these were multiplicatively
combined to create one common mask that included only non-zero
values for all subjects. This mask was applied to all images. Masked
images were log-transformed and subject mean and group mean were
removed, resulting in a Subject Residual Proﬁle per subject. Principal
component analysis (PCA) was applied in voxel space, and the principal
components explaining the top 50% of the total variance were selected
for further analysis.
For each subject, a score was calculated for each principal compo-
nent, by projecting the Subject Residual Proﬁle on each principal
component. Components that gave maximum discrimination between
controls and SCA 3 patients (based on these scores) were identiﬁed with
a stepwise logistic regression procedure, using the lowest Akaike in-
formation criterion of the model as a selection criterion. If more than
one component was identiﬁed, then these components were linearly
combined to form one pattern. Each component in this pattern was
weighted by the coeﬃcient obtained from the logistic regression model.
The ﬁnal pattern was termed the SCA3 related pattern (SCA3-RP).
2.5. Validation of the SCA3-RP
A previously identiﬁed pattern can be used to quantify the FDG-PET
scans of new subjects. In this procedure, an individual's scan is pro-
jected onto the pattern, resulting in a single score (Spetsieris et al.,
S.K. Meles et al. NeuroImage: Clinical 19 (2018) 90–97
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2015). These pattern expression scores can be determined in a new
cohort of patients and controls (a testing set) for validation of the
pattern. A disease-related pattern is considered valid if a signiﬁcant
diﬀerence in pattern expression scores can be demonstrated between
patients and controls in the testing set. After such validation, the pat-
tern may be applied to new images.
In this study, a testing sample was not available. Therefore, we
performed a leave-one-out cross validation (LOOCV) on our identiﬁ-
cation cohort. With LOOCV, SCA3-RP identiﬁcation (i.e. SSM PCA) was
repeated 33 times, each time leaving out one subject. For example,
patient 1 is left out, and the pattern is re-determined on the remaining
16 patients and 16 controls. Subsequently, the subject score of this
pattern is calculated for patient 1. This procedure is then repeated for
each subject, thus generating expression z-scores for each subject
(controls and patients), independent from the pattern identiﬁcation
step. The diﬀerence in LOOCV z-scores between controls and patients
was tested for signiﬁcance with a student's t-test. If signiﬁcant, we
consider the pattern a good predictor of SCA3 in new cases. LOOCV
hereby enables an estimation of diagnostic performance in just one
dataset (Arlot and Celisse, 2010). This approach was also applied in
previous FDG PET SSM PCA studies (Teune et al., 2013)
To determine sensitivity and speciﬁcity of the SCA3-RP, a receiver
operating curve (ROC) was plotted based on the original SCA3-RP z-
scores. The cut-oﬀ z-score that gave optimum sensitivity and speciﬁcity
(based on the ROC inﬂection point) in the identiﬁcation cohort was
chosen as the threshold. This threshold was subsequently applied to the
LOOCV z-scores in controls and patients, and sensitivity and speciﬁcity
of the SCA3-RP was determined.
An important issue is that pattern maps (voxel weights and signs)
can ﬂuctuate depending on which sample of controls and patients was
used for pattern identiﬁcation. Although this variability does not
hamper diagnostic ability (Habeck and Stern, 2010), it is important to
determine which regions in the pattern are stable and can be inter-
preted as part of the pathophysiological process. A statistical approach
to solve this is a bootstrap procedure. This entails repeating the pattern
identiﬁcation process (SSM PCA and subsequent logistic regression)
multiple times on randomly sampled data with replacement. This yields
multiple slightly diﬀerent patterns and thus a distribution of weights
per voxel. Using this distribution, conﬁdence intervals per voxel can be
determined. Voxels with conﬁdence intervals straddling zero can be
interpreted as non-informative and are therefore excluded from the
visualization. Here, we performed 1000 repetitions, and applied a one-
sided conﬁdence interval threshold of 95% (percentile method) fol-
lowed by visualization of the stable voxels.
SSM PCA provides a mathematical decomposition of components
that do not necessarily each have intrinsic biological meaning. The
biological meaning of a pattern is supported when pattern expression
values show a signiﬁcant relationship with other markers of disease.
Therefore, we tested the correlation between SCA3-RP LOOCV z-scores
and SARA (sub)scores. To investigate whether the SCA3-RP topography
may explain neuropsychological deﬁcits in SCA3 patients, we explored
correlations between SCA3-RP LOOCV z-scores and the tests from the
neuropsychology evaluation.
2.6. Statistical analysis
Between-group diﬀerences in age and SCA3-RP z-scores were as-
sessed using the student's t-test. Diﬀerences in SARA scores and neu-
ropsychology test-scores were assessed using the Mann-Whitney U test.
In SCA3 patients, CAG repeat length was correlated to age and age at
onset using a Spearman correlation coeﬃcient. SCA3-RP LOOCV z-
scores were correlated to age and age at onset using Pearson's r corre-
lation coeﬃcient. SCA3-RP LOOCV z-scores were correlated to SARA
(sub)scores, disease duration, CAG repeat length, tests in the language,
executive and memory domains, information processing speed, and
aﬀective symptoms using a Spearman's correlation coeﬃcient. To
correct for multiple comparisons, we considered results to be signiﬁcant
if p < 0.005 (=0.05/10). All analyses were performed using SPSS
software version 23 (SPSS Inc., Chicago, IL).
2.7. Structural MRI analysis
To investigate diﬀerences in grey matter atrophy, a voxel based
morphometry (VBM) analysis was conducted using SPM12 (Ashburner
and Friston, 2000). The T1-weighted MR images were ﬁrst reoriented
manually to ensure that the origin was close to the anterior commis-
sure. Subsequently, images were segmented into grey matter, white
matter, and cerebrospinal ﬂuid. Grey matter segmentations were spa-
tially normalized to MNI-space using the Diﬀeomorphic Anatomical
Registration using Exponentiated Lie algebra (DARTEL), and smoothed
with a 10mm full width at half maximum kernel (Ashburner, 2007). A
two sample t-test was performed to analyze the diﬀerence in brain
atrophy between patients and healthy controls. To correct for inter-
individual diﬀerences in total grey matter volume, data were scaled to
the total grey matter volume per subject (calculated using the Tissue
Volumes function in spm12). Resulting clusters were considered sta-
tistically signiﬁcant if they survived an FWE corrected cluster p value of
0.05 after applying an initial cluster deﬁning threshold of P < 0.001.
Additionally, a region of interest (ROI) analysis was performed to
investigate possible correlations between local grey matter atrophy and
FDG uptake in speciﬁc ROIs. ROIS from the Automated Anatomical
Labeling (AAL) atlas (in MNI space) (Tzourio-Mazoyer et al., 2002)
were selected based on the regions in the SCA3-RP and previous VBM
studies (Hernandez-Castillo et al., 2017) in SCA3. ROIs included the
brainstem, cerebellum (hemispheres and vermis), the caudate nucleus,
putamen, pallidum, occipital lobe, postcentral gyrus, and superior
frontal gyrus.
Binary masks were made for each ROI. Subsequently, these masks
were applied to the individual grey matter segmentations and FDG
images using spm12, yielding total grey matter volume and FDG uptake
for each ROI in every subject. The total FDG uptake in every ROI was
normalized to the total brain uptake of each individual. In case of la-
teralized ROIs, the sum of grey matter volume and FDG uptake of left
and right was used for further analyses. As regional FDG uptake and
grey matter volume were normally distributed, Pearson correlations
were calculated between grey matter volume and FDG uptake in every
ROI using SPSS. Correlations between SARA scores, disease duration,
grey matter volume and FDG uptake in each ROI were explored with




Clinical features of the studied cohort are presented in Table 1. As
expected, higher SARA scores characterized the SCA3 patients. They
further showed signiﬁcantly lower scores on letter ﬂuency and the
SDMT compared to controls. In addition, SCA3 patients had sig-
niﬁcantly higher scores on the HADS depression scale.
Patients with longer CAG repeat lengths had an earlier onset of
symptoms (ρ=−0.78, P < 0.001, Supplementary Fig. 1). CAG repeat
length was also signiﬁcantly and inversely correlated with age
(ρ=−0.82, P < 0.001). This merely reﬂects homogeneity of the stu-
died cohort in terms of clinical presentation. Older patients had lower
CAG repeat lengths and similar clinical severity as younger patients
with more expanded alleles.
3.2. Identiﬁcation of the SCA3-RP
After applying SSM PCA, the ﬁrst seven principal components ex-
plained 50.2% of the total variance, and were used for further analysis.
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A weighted linear combination of components 1 and 5 (relative
weights: 1 and 2.5, respectively; variance explained: 17.0% and 5%
respectively) could best discriminate between controls and patients in
the logistic regression model. The (weighted) linear combination of
components 1 and 5 was termed the SCA3-RP.
SCA3-RP subject z-scores for each subject were entered in a ROC
analysis. The optimum cut-oﬀ z-score was determined at z= 1.26. For
validation, SCA3-RP LOOCV z-scores were obtained. The threshold
(z= 1.26) was applied to the validated scores, which gave a sensitivity
of 70.6% and a speciﬁcity of 93.8%. SCA3-RP LOOCV z-scores are
plotted in Fig. 1, which shows a signiﬁcant diﬀerence between groups
(P < 0.0001).
3.3. Topography of the SCA3-RP
Regions that survived the 95% conﬁdence interval after bootstrap
resampling are displayed in Fig. 2. This visualization was used to draw
conclusions about the most important (and reliable) regions likely to be
involved in SCA3. Stable and consistent relative hypometabolic regions
included the cerebellum and cerebellar vermis, the lower brainstem and
midbrain (tectum), the caudate nucleus, and small clusters in the pos-
terior parietal cortex (left and right precuneus [BA 7] and the right
inferior parietal lobule [BA 39]). Symmetric relative metabolic in-
creases were observed in the cerebellar peduncles, the amygdala, hip-
pocampus, parahippocampal gyrus, the orbitofrontal cortex (BA 11),
insula, the anterior and middle cingulate gyrus and the somatosensory
areas in the parietal cortex (BA 3,2 and 5).
When all, unthresholded voxels in the SCA3-RP are considered
(Supplementary Fig. 2), a highly symmetrical topography is revealed
with lower voxel weights in the cerebellum, striatum and thalamus,
lateral prefrontal cortex, primary motor cortex, medial and posterior
parietal cortex, and the occipital cortex. A visual representation of the
average relative FDG distribution per group (patients and controls se-
parately) is provided in Supplementary Fig. 3.
3.4. Correlation between SCA3-RP expression z-scores and clinical metrics
The SARA scores in patients varied between 3.5 and 15.5 with a
signiﬁcant correlation between these scores and the SCA3-RP LOOCV z-
scores (ρ=0.75, P=0.001; Table 1 and Fig. 3). When SARA sub-scores
were evaluated, SCA3-RP LOOCV expression z-scores correlated sig-
niﬁcantly with gait alteration (ρ=0.59, P=0.013) and disequilibrium
at stance (ρ=0.70, P=0.002), but not with the other sub-scores
(sitting instability, speech disturbance, limb dysmetria and dysdia-
dochokinesia). At alpha=0.005 SCA3-RP LOOCV z-scores were not
signiﬁcantly correlated to neuropsychological test scores (Table 1). At
Table 1
Clinical features of the studied cohort.
Healthy controls (n=16) SCA 3 patients (n=17) P-valueb Correlation with SCA3-RP LOOCV z-scores in SCA3 patients (coeﬃcients and p-
values)
Age, years (range) 49.4 ± 13.5 (20–65) 45.3 ± 11.4 (24–62) 0.36 r=0.03; P=0.91
n Male (%) 8 (50.0) 9 (53.9) 0.87
Age at onset, years (range) 35.6 ± 10.2 (20–55) r= 0.03; P= 0.91
Disease duration (range) 9.7 ± 7 (3−30) r=0.05; P=0.85
CAG repeatsa (range) 70 (65.5–72.5) ρ=0.35; P=0.16
SARAa (range) 0 (0–0.5) 10 (3.5–15.5) < 0.001⁎ ρ=0.75; P=0.001⁎
Level of educationa 5.50 (5–6) 5.0 (5–6) 0.31 ρ=−0.28; P=0.28
Anxiety (HADS) 4.0 ± 2.4 3.5 ± 2.9 0.63 ρ=−0.27; P=0.29
Depression (HADS) 1.6 ± 1.5 5.3 ± 3.5 0.001⁎ ρ=0.03; P=0.90
Semantic Fluency 26.2 ± 7.8 20.0 ± 6.5 0.028 ρ=−0.19; P=0.46
Letter Fluency 38.6 ± 11.5 24.3 ± 12.0 0.001⁎ ρ=−0.51; P= 0.04
Immediate Recall (RAVLT) 50.7 ± 9.0 42.6 ± 9.5 0.021 ρ=−0.19; P=0.48
Delayed Recall (RAVLT) 11.4 ± 3.0 8.8 ± 2.8 0.010 ρ=−0.07; P=0.80
Symbol Digit Modalities Test 62.5 ± 9.6 44.4 ± 8.2 < 0.001⁎ ρ=−0.24; P=0.36
Values are given as mean ± SD unless otherwise speciﬁed.
a Median (interquartile range).
b Independent samples t-test for age, Chi2 for gender, Mann-Whitney U test for remaining variables.
⁎ Signiﬁcant at P < 0.005; RAVLT=Rey Auditory Verbal Learning Test; r= Pearson's r correlation coeﬃcient for parametric variables; ρ=Spearman's rho
correlation coeﬃcient for non-parametric variables.
Fig. 1. Group diﬀerences in SCA3-RP expression z-scores SCA3-RP expression z-
scores were validated with a leave-one-out cross validation (LOOCV) and
plotted for controls and SCA3 patients. The line at y= 1.26 indicates the
threshold, determined on the original SCA3-RP z-scores. Bars indicate mean and
standard deviation.
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the uncorrected signiﬁcance level (P < 0.05), a moderate association
was seen between letter ﬂuency and SCA3-RP LOOCV z-scores
(ρ=−0.51, P=0.04), while letter ﬂuency was also the only neu-
ropsychological parameter that was signiﬁcantly correlated to the
(clinical) SARA scores (ρ=−0.618, P=0.008).
3.5. Relation with grey matter atrophy
VBM analysis revealed signiﬁcant grey matter atrophy in SCA3
patients compared to controls in the cerebellum, bilaterally, including
the right vermis (Table 2). At more lenient threshold (P < 0.01, un-
corrected), regions with decreased grey matter volume included the
striatum, bilaterally, and motor cortex (Fig. 4).
The ROI analyses revealed a signiﬁcant correlation between FDG
uptake and grey matter volume in the cerebellar vermis (r=0.50,
P=0.04; Fig. 5A), although this correlation did not survive correction
for multiple comparisons. In the other ROIs, correlations were not
signiﬁcant (illustrated for the superior parietal cortex in Fig. 5B). SARA
scores were correlated with grey matter volume in the caudate
(ρ=−0.494; P=0.04), and disease duration was correlated with FDG
uptake in the thalamus (ρ=−0.584; P=0.014). These correlations,
however, were weak and did not survive correction for multiple com-
parisons.
4. Discussion
We identiﬁed a spatial metabolic pattern speciﬁc for SCA3 in a
homogenous group of patients. The SCA3-RP was characterized by re-
lative hypometabolism in the cerebellar hemispheres and vermis, the
brainstem, caudate nucleus, and the posterior parietal cortex. Relatively
increased metabolism was found in the cerebellar peduncles, the
amygdala, hippocampus/parahippocampal gyrus, orbitofrontal cortex,
insula, the anterior and middle cingulate gyrus and the somatosensory
cortex.
Relative decreases in the metabolic SCA3-RP may reﬂect either
impaired neuronal function due to cellular pathology at that location,
Fig. 2. Topography of the SCA3-RP. Stable voxels of the SCA3-RP on a T1 MRI template. Red= relative hypermetabolism; Blue= relative hypometabolism. Color
intensity reﬂects the median of the values resulting from the bootstrap resampling. L= left. Coordinates are in Montreal Neurological Institute (MNI) standard space.
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or remote functional network changes due to lesions elsewhere. In the
present study, some of the hypometabolic areas in the SCA3-RP do
indeed overlap with areas known to be aﬀected by pathology (Seidel
et al., 2012; Rub et al., 2008; Rub et al., 2013): cerebellum, lower
brainstem, midbrain, pallidum, thalamus, and primary motor cortex.
However, the comparison of the anatomical MR images (T1) of our
patients with the control MRI's, only revealed signiﬁcant grey matter
volume loss in the bilateral cerebellum and right cerebellar vermis,
which is consistent with the morphological imaging literature
(Hernandez-Castillo et al., 2017; Lukas et al., 2006; Reetz et al., 2013).
Moreover, a (weak) correlation between FDG uptake and grey matter
volume was only found in the cerebellar vermis, and not in other re-
gions, which underscores that the hypometabolic pattern in the SCA3-
RP does not simply reﬂect regional atrophy. As the cerebellum is the
core region of pathology in SCA3, one might have expected a stronger
correlation between grey matter volume and FDG uptake in the cere-
bellum. On the other hand, autopsy-studies have shown that neuronal
loss in the cerebellar cortex is variable. In fact, Schöls et al. re-
ported<25% Purkinje cell loss in most SCA3 cases (Schols et al.,
2004). In addition, Shakkottai et al. demonstrated changes in Purkinje
neuron ﬁring that preceded the onset of Purkinje cell loss in a SCA3
mouse model (Shakkottai et al., 2011). This may provide arguments
that the cerebellar component in the SCA3-RP reﬂects changes in
neuronal activity that are not necessarily a consequence of only
atrophy. The absence of signiﬁcant correlations between FDG reduction
and grey matter atrophy outside the cerebellum, further supports the
involvement of remote functional changes.
Regions aﬀected by neurodegenerative pathology may disrupt the
integrity of distributed networks they participate in. This results in
functional disconnection and dysfunction of spatially remote regions
which are part of the same functional brain system. Due to widespread
involvement of the cerebellum, brainstem, thalamus, pallidum, sub-
thalamic nucleus (STN) and primary motor cortex, many functional
brain systems are indeed aﬀected in SCA3 (Rub et al., 2013). Focal
disruption within the basal ganglia-thalamocortical loop may explain
hypometabolism of the caudate nucleus and the putamen/pallidum.
Moreover, previous studies have shown neuronal loss in the substantia
nigra pars compacta, which was associated with decreased dopamine
transporter binding in the putamen and caudate in SCA3 patients (Rub
et al., 2008; Braga-Neto et al., 2012b; Yen et al., 2002). The combi-
nation of locally progressing pathology and the disruption of complex
interacting motor networks could underlie the variability of the
movement disorder seen in SCA3 (Pedroso et al., 2013).
Hypometabolism of the cerebellum, the posterior parietal cortex
(left and right precuneus [BA7] and right inferior parietal lobule
[BA39]) may reﬂect changes in coherent cerebellar-parietal func-
tioning. As an example, one function to consider is feed-forward pro-
cessing that is involved in predicting the (sensory) consequences of
action (Blakemore and Sirigu, 2003; Ridderinkhof and Brass, 2015;
Roth et al., 2013). A consequence of sub-optimal forward processing in
(higher order) motor control may be an increased demand on actual
movement correction, which is a core feature of ataxia. The latter may
explain the relative increases we observed in the primary (Brodmann
areas 3 and 2) and secondary (Brodmann area 5) somatosensory areas.
Such enhanced anterior parietal activity may therefore represent a
consequence of impaired forward processing in posterior parietal cir-
cuitry implicated in higher-order motor control.
Expression of the SCA3-RP correlated signiﬁcantly with SARA
scores. In contrast, SARA scores did not convincingly correlate to grey
matter loss or FDG uptake in any single region. This supports the in-
terpretation that the SCA3-RP represents network-level changes in
neuronal activity implicated in the pathophysiology underlying ataxia
in SCA3.
At the group-level, SCA3 patients showed impairments in letter
Fig. 3. Correlation between SCA3-RP LOOCV z-scores and SARA scores. Two
subjects had parkinsonism (indicated in red), and one had dystonic features
(blue), while two subjects were relatives from each other (triangles). The outlier
indicated by (*) used levodopa at the time of the study.
Table 2
VBM results (independent samples T-test, SCA3 < controls).







Cerebellum, L −22.5 −64.5 −36 769 5.776251793 0.002
Cerebellum,
R
19.5 −61.5 −33 821 5.176522255 0.002
Cerebellar
vermis, R
10.5 −60 −27 4.56364584
Fig. 4. Brain regions showing grey matter atrophy in SCA3 compared to controls (P < 0.01, cluster extent 50). Only the cerebellar clusters are signiﬁcant at a cluster
deﬁning threshold of P < 0.001, with cluster correction of P < 0.05.
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ﬂuency and processing speed and a moderate association was seen
between letter ﬂuency and SCA3-RP subject scores. The strong asso-
ciation between the SCA3-RP and SARA scores supports the notion that
this pattern primarily reﬂects ataxia, a symptom that all SCA3 patients
have in common, which is not the case for the more variable expression
of cognitive and aﬀective symptoms in the patient group.
Our ﬁndings of relative hypermetabolism in the limbic system, in-
cluding the hippocampus, seem at odds with results of other functional
imaging studies, which have reported hypometabolism (Wang et al.,
2007) and hypoperfusion (Braga-Neto et al., 2012a) of the para-
hippocampal gyrus. In our study, hippocampal hyperactivity may re-
ﬂect relative sparing of this area, but it may also reﬂect a compensatory
mechanism. It is possible that the SCA3-RP changes with disease pro-
gression, and that the hippocampus becomes hypo-active in more ad-
vanced stages of the disease.
In conclusion, this study demonstrates that SCA3 patients exhibit a
metabolic proﬁle that not only includes cerebellum and brainstem, but
also striatum and parietal cortex. The SCA3-RP and its correlation to
clinical measures should be validated in a larger, novel cohort, pre-
ferably also in patients with a shorter disease duration or even in pre-
clinical individuals. In addition, in order to determine the speciﬁcity of
the pattern for SCA3, it would be of interest to compute SCA3-RP ex-
pression in FDG-PET scans of patients with other cerebellar ataxias.
Longitudinal imaging may help understand the metabolic changes with
disease progression, and their relation to clinical features such as cog-
nitive decline. Metabolic patterns may help to predict disease onset in
pre-clinical individuals (Tang et al., 2013). Such imaging biomarkers
may become particularly important in the future, as new therapeutic
interventions are designed with the aim of disease modiﬁcation.
Author's roles
Sanne K. Meles: analysis and interpretation of data, drafting of the
manuscript.
Jelmer G. Kok: acquisition of data, analysis and interpretation of
data, drafting of the manuscript.
Bauke M. De Jong: study concept and design, interpretation of data,
drafting the manuscript, study supervision, critical revision of manu-
script for intellectual content.
Remco J. Renken: supervision of imaging data analysis, critical
revision of manuscript for intellectual content.
Jeroen J. de Vries: acquisition of data, critical revision of manu-
script for intellectual content.
Jacoba M. Spikman: supervision of neuropsychology data analysis,
critical revision of manuscript for intellectual content.
Aaltje L. Ziengs: acquisition of neuropsychology data.
Antoon T.M. Willemsen: acquisition of data, critical revision of
manuscript for intellectual content.
Harm J. van der Horn: analysis and interpretation of data, critical
revision of manuscript for intellectual content.
Klaus L. Leenders: critical revision of manuscript for intellectual
content.
Hubertus P. H. Kremer: study concept and design, interpretation of
data, critical revision of manuscript for intellectual content, study su-
pervision.
Financial disclosure/conﬂict of interest
The authors report no conﬂicts of interest.
Funding
SKM was funded by a grant from the Dutch “Stichting
ParkinsonFonds”. JGK was funded by a grant from the U4 network.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2018.03.038.
References
Andersson, J.L.R., Jenkinson, M., Smith, S., 2007. Non-linear registration aka spatial
normalisation. In: FMRIB Technial Report, (TR07JA2).
Arlot, S., Celisse, A., 2010. A survey of cross-validation procedures for model selection.
Statistics Surveys 4, 40–79.
Ashburner, J., 2007. A fast diﬀeomorphic image registration algorithm. NeuroImage 38,
95–113.
Ashburner, J., Friston, K.J., 2000. Voxel-based morphometry—the methods. NeuroImage
11, 805–821.
Blakemore, S.J., Sirigu, A., 2003. Action prediction in the cerebellum and in the parietal
lobe. Exp. Brain Res. 153, 239–245.
Fig. 5. Correlation between grey matter volume and FDG uptake in the cerebellar vermis (A) and the superior parietal cortex (B).
S.K. Meles et al. NeuroImage: Clinical 19 (2018) 90–97
96
Braga-Neto, P., Dutra, L.A., Pedroso, J.L., et al., 2012a. Cognitive deﬁcits in Machado-
Joseph disease correlate with hypoperfusion of visual system areas. Cerebellum 11,
1037–1044.
Braga-Neto, P., Felicio, A.C., Hoexter, M.Q., et al., 2012b. Cognitive and olfactory deﬁcits
in Machado-Joseph disease: a dopamine transporter study. Parkinsonism Relat.
Disord. 18, 854–858.
Braga-Neto, P., Dutra, L.A., Pedroso, J.L., Barsottini, O.G., 2014. Cognitive dysfunction in
spinocerebellar ataxia type 3: variable topographies and patterns. Mov. Disord. 29,
156–157.
FreeSurfer, Fischl B., 2012. NeuroImage 62, 774–781.
Habeck, C., Stern, Y., Alzheimer's Disease Neuroimaging Initiative, 2010. Multivariate
data analysis for neuroimaging data: overview and application to Alzheimer's disease.
Cell Biochem. Biophys. 58, 53–67.
Hernandez-Castillo, C.R., Diaz, R., Campos-Romo, A., Fernandez-Ruiz, J., 2017. Neural
correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph dis-
ease. Cerebellum Ataxias 4, 7-017-0065-7 (eCollection 2017).
Jenkinson, M., Smith, S., 2001. A global optimisation method for robust aﬃne registra-
tion of brain images. Med. Image Anal. 5, 143–156.
Jenkinson, M., Bannister, P., Brady, M., Smith, S., 2002. Improved optimization for the
robust and accurate linear registration and motion correction of brain images.
NeuroImage 17, 825–841.
Lukas, C., Schols, L., Bellenberg, B., et al., 2006. Dissociation of grey and white matter
reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study.
Neurosci. Lett. 408, 230–235.
Meles, S.K., Teune, L.K., de Jong, B.M., Dierckx, R.A., Leenders, K.L., 2017. Metabolic
imaging in Parkinson disease. J. Nucl. Med. 58, 23–28.
Niethammer, M., Eidelberg, D., 2012. Metabolic brain networks in translational neu-
rology: concepts and applications. Ann. Neurol. 635–647.
Pedroso, J.L., Franca Jr., M.C., Braga-Neto, P., et al., 2013. Nonmotor and extracerebellar
features in Machado-Joseph disease: a review. Mov. Disord. 28, 1200–1208.
Reetz, K., Costa, A.S., Mirzazade, S., et al., 2013. Genotype-speciﬁc patterns of atrophy
progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain
136, 905–917.
Reivich, M., Kuhl, D., Wolf, A., et al., 1979. The [18F]ﬂuorodeoxyglucose method for the
measurement of local cerebral glucose utilization in man. Circ. Res. 44, 127–137.
Ridderinkhof, K.R., Brass, M., 2015. How kinesthetic motor imagery works: a predictive-
processing theory of visualization in sports and motor expertise. J. Physiol. Paris 109,
53–63.
Riess, O., Rub, U., Pastore, A., Bauer, P., Schols, L., 2008. SCA3: neurological features,
pathogenesis and animal models. Cerebellum 7, 125–137.
Roth, M.J., Synofzik, M., Lindner, A., 2013. The cerebellum optimizes perceptual pre-
dictions about external sensory events. Curr. Biol. 23, 930–935.
Rub, U., Brunt, E.R., Deller, T., 2008. New insights into the pathoanatomy of spinocer-
ebellar ataxia type 3 (Machado-Joseph disease). Curr. Opin. Neurol. 21, 111–116.
Rub, U., Schols, L., Paulson, H., et al., 2013. Clinical features, neurogenetics and neu-
ropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog.
Neurobiol. 104, 38–66.
Schmitz-Hubsch, T., du Montcel, S.T., Baliko, L., et al., 2006. Scale for the assessment and
rating of ataxia: development of a new clinical scale. Neurology 66, 1717–1720.
Schols, L., Bauer, P., Schmidt, T., Schulte, T., Riess, O., 2004. Autosomal dominant cer-
ebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol. 3,
291–304.
Segonne, F., Dale, A.M., Busa, E., et al., 2004. A hybrid approach to the skull stripping
problem in MRI. NeuroImage 22, 1060–1075.
Seidel, K., Siswanto, S., Brunt, E.R., den Dunnen, W., Korf, H.W., Rub, U., 2012. Brain
pathology of spinocerebellar ataxias. Acta Neuropathol. 124, 1–21.
Shakkottai, V.G., do Carmo Costa, M., Dell'Orco, J.M., Sankaranarayanan, A., Wulﬀ, H.,
Paulson, H.L., 2011. Early changes in cerebellar physiology accompany motor dys-
function in the polyglutamine disease spinocerebellar ataxia type 3. J. Neurosci. 31,
13002–13014.
Smith, S.M., Jenkinson, M., Woolrich, M.W., et al., 2004. Advances in functional and
structural MR image analysis and implementation as FSL. NeuroImage 23 (Suppl. 1),
S208-19.
Soong, B.W., Liu, R.S., 1998. Positron emission tomography in asymptomatic gene car-
riers of Machado-Joseph disease. J. Neurol. Neurosurg. Psychiatry 64, 499–504.
Soong, B., Cheng, C., Liu, R., Shan, D., 1997. Machado-Joseph disease: clinical, molecular,
and metabolic characterization in Chinese kindreds. Ann. Neurol. 41, 446–452.
Spetsieris, P.G., Eidelberg, D., 2011. Scaled subproﬁle modeling of resting state imaging
data in Parkinson's disease: methodological issues. NeuroImage 54, 2899–2914.
Spetsieris, P.G., Ko, J.H., Tang, C.C., et al., 2015. Metabolic resting-state brain networks
in health and disease. Proc. Natl. Acad. Sci. U. S. A. 112, 2563–2568.
Tang, C.C., Feigin, A., Ma, Y., et al., 2013. Metabolic network as a progression biomarker
of premanifest Huntington's disease. J. Clin. Invest. 123, 4076–4088.
Teune, L.K., Renken, R.J., Mudali, D., et al., 2013. Validation of parkinsonian disease-
related metabolic brain patterns. Mov. Disord. 28, 547–551.
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., et al., 2002. Automated anato-
mical labeling of activations in SPM using a macroscopic anatomical parcellation of
the MNI MRI single-subject brain. NeuroImage 15, 273–289.
Wang, P.S., Liu, R.S., Yang, B.H., Soong, B.W., 2007. Regional patterns of cerebral glucose
metabolism in spinocerebellar ataxia type 2, 3 and 6: a voxel-based FDG-positron
emission tomography analysis. J. Neurol. 254, 838–845.
Wullner, U., Reimold, M., Abele, M., et al., 2005. Dopamine transporter positron emission
tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch. Neurol. 62,
1280–1285.
Yen, T.C., Tzen, K.Y., Chen, M.C., et al., 2002. Dopamine transporter concentration is
reduced in asymptomatic Machado-Joseph disease gene carriers. J. Nucl. Med. 43,
153–159.
S.K. Meles et al. NeuroImage: Clinical 19 (2018) 90–97
97
